Medicamen Biotech Limited (MEDICAMEQ.NS) NSE

383.50

-4.25(-1.10%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap6.27B
Enterprise Value6.57B
P/E Ratio64.54
PEG Ratio10.28
Price/Sales Ratio3.15
Price/Book Ratio2.38
Enterprise/Revenue3.12
Enterprise/EBITDA24.44

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.06
Operating Margin0.05

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue1.63B
Revenue/Share96.5
Gross Profit389.9M
EBITDA201.02M
Net Income71.08M
Diluted EPS5.59

Balance Sheet

Total Cash436.79M
Total Cash/Share25.55
Total Debt386.49M
Total Debt/Equity0.14
Current Ratio2.61
Book Value Per Share161.11

Price History

52-Week Change-25.98
52-Week High560.7
52-Week Low292.95
Moving Average 50 Days380.6
Moving Average 200 Days397.33

Statistics

Average Volume44,993
Shares Outstanding13.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield0.26
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A